tiprankstipranks
Supernus Pharmaceuticals (GB:0LB2)
LSE:0LB2

Supernus Pharmaceuticals (0LB2) Balance Sheet

0 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q3 2023 were $1.29B, a decrease of -0.61% from the previous quarter. GB:0LB2 total liabilities were $372.97M for the fiscal quarter, a -0.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 1.70B$ 1.69B$ 1.50B$ 1.16B$ 977.81M
Total Liabilities
$ 816.30M$ 873.30M$ 759.24M$ 564.85M$ 524.79M
Total Equity Gross Minority
$ 886.20M$ 815.85M$ 744.86M$ 595.43M$ 453.02M
Total Capitalization
$ 922.20M$ 1.20B$ 1.11B$ 940.60M$ 782.49M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 52.57M$ 33.27M$ 0.00
Currency in USD

Supernus Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis